BioConcept Ltd.
Making Recombination Protein Production Seamless

Since its inception in 1992, BioConcept Ltd. has evolved from a producer of cell culture media for the research market into a recognized service provider for the pharmaceutical and biotechnology market. BioConcept Ltd. meets the high requirements in the areas of manufacturing, cleaning, quality control, and documentation and offers a high degree of flexibility in terms of customer formulations and customized packaging.

“We believe that only high-quality products lead to longterm market success and generate customer satisfaction and reputation,” says Martin Howald, CEO and president of BioConcept Ltd.

BioConcept Ltd. has, over the years, expanded its specialty and high-quality product range. The company is able to produce media, powders, and buffers according to customer requirements.

In addition, together with its cell line development partners, it has developed the proprietary media for the production of recombinant proteins and antibodies for use in therapeutic programs.

“Our nimble company architecture, specialized employees, and extensive experience allow us to address customer requests rather quickly and readily,” says Howald.

As BioConcept Ltd. interacts closely with its customers and listens to their needs and requirements, it receives valuable feedback from customers that helps improve products and services. Through regular customer audits, the company optimizes its processes and the quality of its products and services.

During the pandemic period, BioConcept Ltd. was quick to respond to the need for Covid vaccine manufacturing initiative and provide large quantities of buffers. Additionally, it also continued the production of CHO production media and biosimilars at the same time. This was accomplished without any impact or delay to its pharma customers, who rely on these products for various cancer therapies globally.

Even in the post-pandemic world, BioConcept Ltd. has managed to continue to guarantee high quality and short delivery times for its products and services. The company has been able to meet production dates and deadlines, and its flexibility has ensured that customers meet their own commitments and delivery dates.

“We continue to work intensively on the expansion of our distributor and customer network and are eager to establish strategic partnerships to bring our products and services to a larger and broader customer base,” says Howald.